Swedish EU Presidency Promises Action On Pharma Law Revision, EMA Fees & AMR
Executive Summary
Health care and medicines are among the priorities outlined by the new presidency of the Council of the EU for the first half of 2023.
You may also be interested in...
New EU Fee System To Give Pharma Firms More Predictability
The publication of a draft EU Regulation governing the fees paid by the pharmaceutical industry to the European Medicines Agency is the latest step in a long process aimed at ensuring that the payment system better reflects the actual costs of the regulatory work carried out or coordinated by the EU regulator.
Countries To Discuss Pandemic Treaty Next Year Amid Industry Concern
A World Health Organization negotiating body has agreed to develop a “zero draft” of the proposed pandemic treaty for discussion at a meeting of WHO member states in February next year. But the international pharmaceutical industry has reiterated its concerns about some of the proposals being put forward.
EU Wants Legislative Review To Support ‘World Class’ Pharmaceutical Industry
The European health commissioner has told members of parliament that a balance needs to be struck between promoting innovation and maximizing access to medicines across the EU member states.